Interaction between β-amyloid protein and the α7 nicotinic acetylcholine receptor in cholinergic, gabaergic and calcium-binding proteins-containing neurons in the septum-diagonal band complex of the rat

European Journal of Anatomy

Volumn 10, Issue 3, 2006, Pages 127-142

  Gonzalo Ruiz, A ^a   Arevalo Serrano J ^b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Alzheimer's disease; Basal forebrain; Calcium binding protein; Cholinergic transmission; GABAergic transmission; Posterior cingulate cortex

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMYLOID BETA PROTEIN; BUNGAROTOXIN RECEPTOR; CALCIUM BINDING PROTEIN; CHOLINERGIC RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DIAGONAL BAND OF BROCA; FEMALE; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; NONHUMAN; PROTEIN PROTEIN INTERACTION; RAT;

EID: 33947727475     PISSN: 11364890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. APELT J, KUMAR A and SCHLIEBS R (2002). Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein. Brain Res, 953: 17-30.
2. AULD DS, KORNECOOK TJ, BASTIANETTO S and QUIRION R (2002). Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol, 68: 209-245.
3. BELL KA, O'RIORDAN KJ, SWEATT JD and DINELEY KT (2004). MAPK recruitment by beta-amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time. J Neurochem, 91: 349-361.
4. BIGL M, APELT J, LUSCHEKINA EA, LANGE-DOHNA C, ROBNER S and SCHLIEBS R (2000). Expression of β-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology. Neuroscience Lett, 292: 107-110.
5. COURT J, MARTIN-RUIZ C, PIGGOTT M, SPURDEN D, GRIFFITHS M and PERRY E (2001). Nicotinic receptor abnormalities in Alzheimer's disease. Biol Psychiatr, 49: 175-184.
6. DAHLGREN KN, MANELLI AM, STINE WB JR, BAKER LK, KRAFFT GA and LA DU MJ (2002). Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem, 277: 32046-32053.
7. DINELEY KT, BELL KA, BUI D and SWEATT JD (2002a). Beta-amyloid peptide activates α7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Biol Chem, 277: 25056-25061.
8. DINELEY KT, XIA X, BUI D, SWEATT JD and ZHENG H (2002b). Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem, 277: 22768-22780.
9. DOMINGUEZ DEL TORO T, JUIZ JM, PENG X, LINDSTROM J and CRIADO M (1994). Immunocytochemical localization of the alpha 7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. J Comp Neurol, 349: 325-342.
10. FABIAN-FINE R, SKEHEL P, ERRINGTON ML, DAVIS HA, SHER E, STEWART MG and FINE A (2001). Ultrastructural distribution of the α7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci, 21: 7993-8003.
11. FIBIGER HC (1991). Cholinergic mechanisms in learning, memory and dementia: A review of recent evidence. Trend Neurosci, 14: 230-233.
12. FREUND TF and ANTAL M (1988). GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus. Nature, 36: 170-173.
13. GABRIEL M, LAMBERT RW, FOSTER K, ORONA E, SPARENBORG S and MAIORCA RR (1983). Anterior thalamic lesions and neuronal activity in the cingulate and retrosplenial cortices during discriminative avoidance behavior in rabbits. Behav Neurosti, 97: 675-696.
14. GE S and DANI JA (2005). Nicotinic acetylcholine receptors at glutamate synapses facilitate long-term depression or potentiation. J Neurosci, 25: 6084-6091.
15. GIOVANNELLI L, CASAMENTI F, SCALI C, BARTOLINI L and PEPEU G (1995). Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience, 66: 1113-1117.
16. GIOVANNELLI L, SCALI C, FAUSSONE- PELLEGRINI MS, PEPEU G and CASAMENTI F (1998). Long-term changes in the aggregation state and toxic effects of β-amyloid injected into the rat brain. Neuroscience, 87: 349-357.
17. GONZALO-RUIZ A and MORTE L (2000). Localization of amino acid, neuropeptides and cholinergic neurotransmitter markers in neurons of the septum-diagonal band complex projecting to the retrosplenial granular cortex of the rat. Brain Res Bull, 52: 499-510.
18. GONZALO-RUIZ A and SANZ JM (2002). Alteration of cholinergic, excitatory amino acid and neuropeptide markers in the septum-diagonal band complex following injections of fibrillar β-amyloid protein into the retrosplenial cortex of the rat. Eur J Anat, 6: 58-71.
19. GONZALO-RUIZ A, GONZÁLEZ I and SANZ-ANQUELA JM (2003). Effects of β-amyloid protein on serotoninergic, noradrenergic, and cholinergic markers in neurons of the pontomesencephalic tegmentum in the rat. J Chem Neuroanat, 26: 153-170.
20. GONZALO-RUIZ A, GONZALO P and ARÉVALO J (2004a). Beta-amyloid-induced neuronal loss correlates with gliosis that potentiate glutamate and cholinergic receptors activities in the cerebral cortex of the rat. Soc Neurosti Abst, Program No 217.17.
21. GONZALO-RUIZ A, GONZÁLEZ I, ARÉVALO J, PÉREZ JL and GONZALO P (2004b). Beta-amyloid affects acetylcholine receptors in cholinergic, GABAergic and calcium-binding proteins-containing neurons in the septal complex of the rat. Int J Dev Neurosci, 22 (Suppl): 578-579.
22. GONZALO-RUIZ A, SANZ JM, ARÉ VALO J, GEULA C and GONZALO P (2005). Amyloid beta peptide-induced cholinergic fibres loss in the cerebral cortex of the rat is modified by diet high in lipids and by age. J Chem Neuroanat, 29: 31-48.
23. GONZALO-RUIZ A, PÉREZ JL, SANZ JM, GEULA C and ARÉVALO J (2006). Effects of lipids and aging on the neurotoxicity and neuronal loss caused by intracerebral injections of the amyloid-β peptide in the rat. Exp Neurol, 197: 41-55.
24. GUAN ZZ, MIAO H, TIAN JY, UNGER C, NORDBERG A and ZHANG X (2001). Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells. J Neural Transm, 108: 1417-1433.
25. HARKANY T, HORTOBAGYI T, SASVARI M., KONYA C, PENKE B, LUITEN PG and NYAKAS C (1999). Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: Relevance to Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry, 23: 963-1008.
26. HARKANY T, O'MAHONY S, KEIJSER J, KELLY JP, KONYA C, BOROSTYANKO ZA, GORES TJ, ZARANDI M, PENKE B, LEONARD BE and LUITEN PGM (2001). Beta-amyloid (1-42)-induced cholinergic lesions in the rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex. Neurobiol Dis, 8: 667-678.
27. HARTMANN J, ERB C, EBERT U, BAUMANN KH, POPP A, KONIG G and KLEIN J (2004). Central cholinergic function in human amyloid precursor protein knock-in/presenilin-1 transgenic mice. Neuroscience, 125: 1009-1017.
28. HELLSTROM-LINDAHL E, MOUSAVI M, ZHANG X, RAVID R and NORDBERG A (1999). Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Brain Res Mol, 66: 94-103.
29. HENDERSON Z, BOROS A, JANZSO G, WESTWOOD AJ, MONYER H and HALASY K (2005). Somato-dendritic nicotinic receptor responses recorded in vitro from medial septal diagonal band complex of the rodent. J Physiol, 562:165-182.
30. HERBER DL, SEVERANCE EG, CUEVAS J, MORGAN D and GORDON MN (2004). Biochemical and histochemical evidence of nonspecific binding of α7nAChR antibodies to mouse brain tissue. J Histochem Cytochem, 52: 1367-1376.
31. HU L, WONG TP, COTE SL, BELL KF and CUELLO AC (2003). The impact of A beta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in Alzheimer's disease-like transgenic mice. Neuroscience, 121: 421-432.
32. JI D, LAPE R and DANI JA (2001). Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron, 31: 131-141.
33. JONES IW and WONNACOTT S (2005). Why doesn't nicotinic ACh receptor immunoreactivity knock-out? Trends Neurosci, 28: 343-345.
34. KAR S, SLOWIKOWSKI SPM, WESTAWAY D and MOUNT HTJ (2004). Interaction between β-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J Psychiatry Neurosci, 29: 427-441.
35. KEM WR (2000). The brain alpha 7 nicotinic acetylcholine receptor may be an important therapeutic target for the treatment of Alzheimer's disease studies with DMXBA (GTS-21). Behav Brain Res, 113: 169-181.
36. KOHLER C, CHAN-PALAY V and WU JY (1984). Septal neurons containing glutamic acid decarboxylase immunoreactivity project to the hippocampal region in the rat brain. Anat Embryol, 169: 41-44.
37. KOWALL NW, BEAL MF, BUSCIGLIO J, DUFFY LK and YANKNER BA (1991). An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance P. Proc Nat Acad Sci USA, 88: 7247-7251.
38. LEANZA G (1998). Chronic elevation of amyloid precursor protein expression in the neocortex and hippocampus of rats with selective cholinergic lesions. Neurosci Lett, 257: 53-56.
39. LEE DHS and WANG HY (2003). Differential physiologic responses of alpha 7 nicotinic acetylcholine receptors to beta-amyloid 1-40 and beta-amyloid 1-42. J Neurobiol, 55: 25-30.
40. LEE DHS, D'ANDREA MR, PLATA-SALAMAN CR and WANG HY (2000). Decreased α7 nicotinic acetylcholine receptor levels in sporadic Alzheimer's disease hippocampus. Alzheimer Rep, 3: 217-220.
41. LEHERICY S, HIRSCH EC, CERVERA-PIEROT P, HERSCH LB, BAKCHINE S, PIETTE F, DUYCKAERTS C, HAUW JJ, JAVOY-AGID F and AGID Y (1993). Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J Comp Neurol, 330:15-31.
42. LEVEY AI, BOLAM JP, RYE DB, HALLANGER AE, DEMUTH RM and MESULAM MM (1986). A light and electron microscopic procedure for sequential double antigen localization using diaminobenzidine and benzidine dihydrochloride. J Histochem Cytochem, 11: 1449-1457.
43. LEVIN ED and REZVANI AH (2000). Development of nicotinic drug therapy for cognitive disorders. Eur J Pharmacol, 393:141-146.
44. LEVIN ED, BETTEGOWDA C, BLOSSER J and GORDON J (1999). AR-R17779, and alpha 7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol, 10: 675-680.
45. Liu Q, Kawai H and Berg DK (2001). Beta-amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci USA, 98: 4734-4739.
46. MESULAM MM, MUFSON EJ, LEVEY AI and WAINER BH (1983). Cholinergic innervation of cortex by the basal forebrain cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol, 214:170-197.
47. NAGELE RG, D'ANDREA MR, ANDERSON WJ and Wang HY (2002). Intracellular accumulation of β-amyloid 1-42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience, 110: 199-211.
48. NORDBERG A (1994). Human nicotinic receptors-their role in aging and dementia. Neurochem Int, 25: 93-97.
49. NORDBERG A (2001). Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol Psychiatry, 49: 200-210.
50. PAXINOS G and WATSON C (1986). The rat brain in stereo-taxic coordinates, 2nd ed. Academic Press, New York.
51. QUICK M, PHILIE J and CHOREMIS J (1997). Modulation of α7 nicotinic receptor-mediated calcium influx by nicotinic agonist. Mol Pharmacol, 51: 499-506.
52. REYES AE, CHACÓN MA, DINAMARCA MC, CERPA W, MORGAN C and INESTROSA NC (2004). Acetylcholinesterase-Aβ complexes are more toxic than Aβ fibrils in rat hippocampus. Am J Pathol, 164: 2163-2174.
53. ROBNER S, UEBERHAM U, YU J, KIRAZOV L, SCHLIEBS R, PEREZ-POLO JR And BIGL V (1997). In vivo regulation of amyloid precursor protein secretion in rat neocortex by cholinergic activity. Eur J Neurosci, 9: 2125-2134.
54. SABBAGH MN, LUKAS RJ, SPARKS DL and REID RT (2002). The nicotinic acetylcholine receptor, smoking, and Alzheimer's disease. J Alzheimer's Dis, 4: 317-325.
55. SEGUELA P, WADICHE J, DINELEY-MILLER K, DANI JA and Patrick JW (1993). Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J Neurosci, 13: 596-604.
56. SELKOE DJ (1991). The molecular pathology of Alzheimer's disease. Neuron, 6: 487-498.
57. SELKOE DJ (2003). Folding proteins in fatal ways. Nature, 426: 900-904.
58. SELKOE DJ (2005). Defining molecular targets to prevent Alzheimer disease. Arch Neurol, 62: 192-195.
59. SHIN R, OGINO K, KONDO A, SAIDO TC, TROJANOWSKI JQ, KITAMOTO T and TATEISHI J (1997). Amyloid β-protein (Aβ)1-40 but not Aβ1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain. J Neurosci, 17: 8187-8193.
60. SICK CJ, ROGERS JA, KOCSIS B and HAJÓS M (2006). Activation of α7 acetylcholine receptors augments stimulation-induced hippocampal theta oscillation. Eur J Neurosci, 23: 570-574.
61. SPENCER JP, WEIL A, HILL K, HUSSAIN I, RICHARDSON JC, CUSDIN FS, CHEN YH and RANDALL AD (2005). Transgenic mice over-expressing human β-amyloid have functional nicotinic alpha 7 receptors. Neuroscience, 137: 795-805.
62. SUTHERLAND RJ and HOESING JM (1993). Posterior cingulate cortex and spatial memory: A microlimnology analysis. In: Vogt B, Gabriel M (eds). Neurobiology of cingulate cortex and limbic thalamus: A comprehensive handbook. Birhaüser, Boston, pp 461-477.
63. TEAKTONG T, GRAHAM A, COURT J, PERRY R, JAROS E, JOHNSON M, HALL R and PERRY E (2003). Alzheimer's disease is associated with a selective increase in alpha nicotinic acetylcholine receptor immunoreactivity in astrocytes. Glia, 41: 207-211.
64. THINSCHMIDT JS, FRAZIER CJ, KING MA, MEYER EM and PAPKE R (2005). Medial septal/diagonal band cells express multiple functional nicotinic receptor subtypes that are correlated with firing frequency. Neurosci Lett, 389: 63-168.
65. VAN KAMPEN M, SELBACH K, SCHNEIDER R, SCHIEGEL E, BOESS F and SCHREIDER R (2004). AR-R 17779 improves social recognition in rats by activation of nicotinic alpha 7 receptors. Psychopharmacology, 172: 375-383.
66. VASSAR R and CITRON M (2000). A beta-generating enzymes: recent advances in beta- and gamma-secretase research. Neuron, 27: 419-422.
67. VERTES RP and KOCSIS B (1997). Brainstem-diencephalon- septohippocampal systems controlling the theta rhythm of the hippocampus. Neuroscience, 81: 893-926.
68. VOGT BA and PETERS A (1981). Form and distribution of neurons in rat cingulate cortex: areas 32, 24 and 29. J Comp Neurol, 195: 603-625.
69. WALSH DM and SELKOE DJ (2004). Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron, 44: 181-193.
70. WALSH DT, MONTERO RM, BRESCIANI LG, JEN AY, LECLERCQ PD, SAUND D, EL-A MIR AN, GBADAMOSHI L, GENTLEMAN SM and JEN LS (2002). Amyloid-beta peptide is toxic to neurons in vivo via indirect mechanisms. Neurobiol Dis, 10: 20-27.
71. WANG HY, LI W, BENEDETTI NJ and LEE DH (2003). Alpha 7 nicotinic acetylcholine receptors mediate beta-amyloid peptide-induced tau protein phosphorylation. J Biol Chem, 278: 31547-31553.
72. WEVERS A, BURGHAUS L, MOSER N, WITTER B, STEINLEIN OK, SCHUTZ U, ACHNITZ B, KREMPEL U, NOWACKI S, PILZ K, STOODT J, LINDSTROM J, DE VOS RA, JANSEN STEUR EN and SCHRÖDER H (2000). Expression of nicotinic acetylcholine receptors in Alzheimer's disease. Post-mortem investigations and experimental approaches. Behav Brain Res, 113: 207-215.
73. WHITEHOUSE PJ and KALARIA RN (1995). Nicotinic receptors and neurodegenerative dementing disease: basic research and clinical implications. Alzheimer Dis Assoc Disord, 9: 3-5.
74. WHITEHOUSE PJ, PRICE DL, CLARK AW, COYLE JT and DELONG MR (1981). Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol, 10: 122-126.
75. WHITEHOUSE PJ, PRICE DL, STRUBLE RG, COYLE JT and DELONG MA (1982). Alzheimer's disease and senile dementia-loss of neurons in the basal forebrain. Science, 215: 1237-1239.
76. WINKLER J, CONNOR DJ, FRAUTSCHY SA, BEHL C, WAITE JJ, COLE G and THAL LJ (1994). Lack of long-term effects after β-amyloid protein injections in rat brain. Neurobiol Aging, 15: 601-607.
77. XIU J, NORDBERG A, ZHANG JT and GUAN ZZ (2005). Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the α7, α4 and β2 subunits in response to nanomolar concentrations of the β-amyloid peptide 1-41. Neurochem Int, 47: 281-290.
78. YANG X, CRISWELL HE and BREESE GR (1996). Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid-containing neurons. J Pharmacol Exp Ther, 276: 482-489.
79. YANKNER BA and MESULAM MM (1991). Beta-amyloid and the pathogenesis of Alzheimer's disease. New Eng J Med, 325: 1849-1857.
80. YOUNG JW, FINLAYSON K, SPRATT C, MARSTON HM, CRAWFORD N, KELLY JS and SHARKEY J (2004). Nicotine improves sustained attention in mice: evidence for involvement of the alpha 7 nicotinic acetylcholine receptor. Neuropsychopharmacology, 29: 281-900.
81. YU WF, GUAN ZZ, BOGDANOVIC N and NORDBERG A (2005). High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritis plaques. Exp Neurol, 192: 215-225.